Impact BioMedical
IBO----
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Impact BioMedical(IBO) the Revenue is 3 K (-57.14%);the EBIT is -702 K (+39.12%);the EPS is -0.126 (+99.15%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B57.14%
----
----
EBIT
-0.00B39.12%
----
----
EPS
-0.126299.15%
----
----
Upcoming earnings report - Q3 FY2026
Available dateNov 6, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly